In this issue:
Tenecteplase vs alteplase before thrombectomy
Fremanezumab for prevention of episodic migraine
Rivaroxaban for stroke prevention after embolic stroke
Oral BACE-1 inhibitor verubecestat in Alzheimer disease
Anticholinergic drugs and risk of dementia
Exercise training in patients with dementia
Five-year risk of stroke after TIA or minor ischaemic stroke
Projected stroke volumes in NZ
Impact of telestroke service discontinuation
Riluzole treatment prolongs survival in ALS stage 4
Please login below to download this issue (PDF)